Pharmacology · Pathway 17
Methotrexate
Key points
- Methotrexate: folic acid antagonist — inhibits dihydrofolate reductase → ↓ DNA synthesis.
- Uses: rheumatoid arthritis, psoriasis, some cancers; given ONCE WEEKLY (daily dosing errors are dangerous).
- Side effects: myelosuppression, liver fibrosis, pneumonitis, teratogenicity.
- Monitoring: FBC, U&E and LFTs before treatment and regularly after; prescribe folic acid (e.g. 5 mg weekly, different day).
- Interactions: NSAIDs and trimethoprim increase toxicity.
Decision points in this pathway
- Toxicity suspected? (↓counts, deranged LFTs, cough/dyspnoea)
The full step-by-step algorithm, including what to do at each branch, opens in the app for approved members.